Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)

China flag China · Delayed Price · Currency is CNY
9.02
-0.23 (-2.49%)
Jun 11, 2026, 11:29 AM CST
Market Cap4.06B +6.9%
Revenue (ttm)2.47B +3.2%
Net Income16.84M
EPS0.03
Shares Out 438.41M
PE Ratio240.85
Forward PE31.90
Dividend0.30 (3.21%)
Ex-Dividend DateJun 4, 2026
Volume7,020,400
Open9.17
Previous Close9.25
Day's Range8.98 - 9.28
52-Week Range8.99 - 14.37
Beta0.50
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About SHA:603520

Zhejiang Starry Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical raw materials in China and internationally. It operates through Contrast Agent Series, Quinolone Series, CMO/CDMO, and Others segments. The company offers preparation products comprising iohexol, iopamidol, iodixanol, iomeprol, ioversol, and gadobenate dimeglumine injections; contrast agent APIs and intermediates consisting of iohexol, iopamidol, iodixanol, ioversol, iopromide, iomeprol, gadobenat... [Read more]

Sector Healthcare
Founded 1997
Employees 1,905
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603520
Full Company Profile

Financial Performance

Financial Statements